Wu Wenjuan, Lin Keqin, Yang Yanni, Dong ZhaoXing, Zhang Tao, Lei Wen, Yang Weimin, Yang Zhaoqing
School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University.
The second affiliated hospital of Kunming Medical University, 374 Dianmian Avenue, Kunming, China.
Medicine (Baltimore). 2019 Aug;98(33):e16899. doi: 10.1097/MD.0000000000016899.
Hermansky-Pudlak syndrome (HPS) is a rare autosomal recessive multisystem disorder characterized by oculocutaneous albinism (OCA) and bleeding diathesis, although it displays both genetic and phenotypic heterogeneity. Several genetic subtypes of HPS have been identified in human; however, the characterizations of HPS type 4 (HPS-4) genotype and phenotype remain unclear. This study was aimed to identify gene mutation responsible for HPS-4 with pulmonary fibrosis (PF).Two Chinese siblings in their 50 s afflicted with OCA and progressive dyspnea were recruited and underwent clinical and genetic examinations. In both patients, chest high-resolution computerized tomography showed severe interstitial PF in bilateral lung fields, and the pulmonary function test indicated restrictive lung disease. A novel homozygous frameshift mutation (NM_022081: c.630dupC; p.A211fs) in the HPS4 gene was identified by whole-exome sequencing analysis followed by Sanger DNA sequencing, and it segregated with the phenotypes. The c.630dupC mutation was not found in unaffected healthy controls. The patients were considered as HPS-4 with interstitial PF and eventually died of respiratory failure.This is the first report on the genotype and clinical phenotype of HPS-4 in China. Our results demonstrate the association between a novel frameshift mutation in HPS4 and severe PF with poor prognosis in HPS is presented.
Hermansky-Pudlak综合征(HPS)是一种罕见的常染色体隐性多系统疾病,其特征为眼皮肤白化病(OCA)和出血素质,尽管它表现出遗传和表型的异质性。人类已鉴定出几种HPS的遗传亚型;然而,HPS 4型(HPS-4)的基因型和表型特征仍不清楚。本研究旨在鉴定导致伴有肺纤维化(PF)的HPS-4的基因突变。招募了两名50多岁患有OCA和进行性呼吸困难的中国同胞,并对其进行了临床和基因检查。两名患者胸部高分辨率计算机断层扫描均显示双侧肺野严重间质PF,肺功能测试提示限制性肺病。通过全外显子组测序分析,随后进行桑格DNA测序,在HPS4基因中鉴定出一种新的纯合移码突变(NM_022081: c.630dupC;p.A211fs),且该突变与表型共分离。在未受影响的健康对照中未发现c.630dupC突变。这两名患者被认为是伴有间质PF的HPS-4,最终死于呼吸衰竭。这是中国关于HPS-4基因型和临床表型的首次报告。我们的结果表明,HPS4中一种新的移码突变与HPS中严重PF及预后不良之间存在关联。